464 related articles for article (PubMed ID: 22005185)
1. 2D MI-DRAGON: a new predictor for protein-ligands interactions and theoretic-experimental studies of US FDA drug-target network, oxoisoaporphine inhibitors for MAO-A and human parasite proteins.
Prado-Prado F; García-Mera X; Escobar M; Sobarzo-Sánchez E; Yañez M; Riera-Fernandez P; González-Díaz H
Eur J Med Chem; 2011 Dec; 46(12):5838-51. PubMed ID: 22005185
[TBL] [Abstract][Full Text] [Related]
2. NL MIND-BEST: a web server for ligands and proteins discovery--theoretic-experimental study of proteins of Giardia lamblia and new compounds active against Plasmodium falciparum.
González-Díaz H; Prado-Prado F; Sobarzo-Sánchez E; Haddad M; Maurel Chevalley S; Valentin A; Quetin-Leclercq J; Dea-Ayuela MA; Teresa Gomez-Muños M; Munteanu CR; José Torres-Labandeira J; García-Mera X; Tapia RA; Ubeira FM
J Theor Biol; 2011 May; 276(1):229-49. PubMed ID: 21277861
[TBL] [Abstract][Full Text] [Related]
3. Using entropy of drug and protein graphs to predict FDA drug-target network: theoretic-experimental study of MAO inhibitors and hemoglobin peptides from Fasciola hepatica.
Prado-Prado F; García-Mera X; Abeijón P; Alonso N; Caamaño O; Yáñez M; Gárate T; Mezo M; González-Warleta M; Muiño L; Ubeira FM; González-Díaz H
Eur J Med Chem; 2011 Apr; 46(4):1074-94. PubMed ID: 21315497
[TBL] [Abstract][Full Text] [Related]
4. 3D MI-DRAGON: new model for the reconstruction of US FDA drug- target network and theoretical-experimental studies of inhibitors of rasagiline derivatives for AChE.
Prado-Prado F; García-Mera X; Escobar M; Alonso N; Caamaño O; Yañez M; González-Díaz H
Curr Top Med Chem; 2012; 12(16):1843-65. PubMed ID: 23030618
[TBL] [Abstract][Full Text] [Related]
5. Unified QSAR approach to antimicrobials. Part 3: first multi-tasking QSAR model for input-coded prediction, structural back-projection, and complex networks clustering of antiprotozoal compounds.
Prado-Prado FJ; González-Díaz H; de la Vega OM; Ubeira FM; Chou KC
Bioorg Med Chem; 2008 Jun; 16(11):5871-80. PubMed ID: 18485714
[TBL] [Abstract][Full Text] [Related]
6. MIND-BEST: Web server for drugs and target discovery; design, synthesis, and assay of MAO-B inhibitors and theoretical-experimental study of G3PDH protein from Trichomonas gallinae.
González-Díaz H; Prado-Prado F; García-Mera X; Alonso N; Abeijón P; Caamaño O; Yáñez M; Munteanu CR; Pazos A; Dea-Ayuela MA; Gómez-Muñoz MT; Garijo MM; Sansano J; Ubeira FM
J Proteome Res; 2011 Apr; 10(4):1698-718. PubMed ID: 21184613
[TBL] [Abstract][Full Text] [Related]
7. Unified QSAR approach to antimicrobials. 4. Multi-target QSAR modeling and comparative multi-distance study of the giant components of antiviral drug-drug complex networks.
Prado-Prado FJ; Martinez de la Vega O; Uriarte E; Ubeira FM; Chou KC; González-Díaz H
Bioorg Med Chem; 2009 Jan; 17(2):569-75. PubMed ID: 19112024
[TBL] [Abstract][Full Text] [Related]
8. Multi-target spectral moments for QSAR and Complex Networks study of antibacterial drugs.
Prado-Prado FJ; Uriarte E; Borges F; González-Díaz H
Eur J Med Chem; 2009 Nov; 44(11):4516-21. PubMed ID: 19631422
[TBL] [Abstract][Full Text] [Related]
9. New Markov-Shannon Entropy models to assess connectivity quality in complex networks: from molecular to cellular pathway, Parasite-Host, Neural, Industry, and Legal-Social networks.
Riera-Fernández P; Munteanu CR; Escobar M; Prado-Prado F; Martín-Romalde R; Pereira D; Villalba K; Duardo-Sánchez A; González-Díaz H
J Theor Biol; 2012 Jan; 293():174-88. PubMed ID: 22037044
[TBL] [Abstract][Full Text] [Related]
10. Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Santana L; González-Díaz H; Quezada E; Uriarte E; Yáñez M; Viña D; Orallo F
J Med Chem; 2008 Nov; 51(21):6740-51. PubMed ID: 18834112
[TBL] [Abstract][Full Text] [Related]
11. Ligand-based virtual screening and in silico design of new antimalarial compounds using nonstochastic and stochastic total and atom-type quadratic maps.
Marrero-Ponce Y; Iyarreta-Veitía M; Montero-Torres A; Romero-Zaldivar C; Brandt CA; Avila PE; Kirchgatter K; Machado Y
J Chem Inf Model; 2005; 45(4):1082-100. PubMed ID: 16045304
[TBL] [Abstract][Full Text] [Related]
12. Multi-target spectral moment: QSAR for antiviral drugs vs. different viral species.
Prado-Prado FJ; Borges F; Uriarte E; Peréz-Montoto LG; González-Díaz H
Anal Chim Acta; 2009 Oct; 651(2):159-64. PubMed ID: 19782806
[TBL] [Abstract][Full Text] [Related]
13. A QSAR model for in silico screening of MAO-A inhibitors. Prediction, synthesis, and biological assay of novel coumarins.
Santana L; Uriarte E; González-Díaz H; Zagotto G; Soto-Otero R; Méndez-Alvarez E
J Med Chem; 2006 Feb; 49(3):1149-56. PubMed ID: 16451079
[TBL] [Abstract][Full Text] [Related]
14. Dragon method for finding novel tyrosinase inhibitors: Biosilico identification and experimental in vitro assays.
Casañola-Martín GM; Marrero-Ponce Y; Khan MT; Ather A; Khan KM; Torrens F; Rotondo R
Eur J Med Chem; 2007; 42(11-12):1370-81. PubMed ID: 17637486
[TBL] [Abstract][Full Text] [Related]
15. MISS-Prot: web server for self/non-self discrimination of protein residue networks in parasites; theory and experiments in Fasciola peptides and Anisakis allergens.
González-Díaz H; Muíño L; Anadón AM; Romaris F; Prado-Prado FJ; Munteanu CR; Dorado J; Sierra AP; Mezo M; González-Warleta M; Gárate T; Ubeira FM
Mol Biosyst; 2011 Jun; 7(6):1938-55. PubMed ID: 21468430
[TBL] [Abstract][Full Text] [Related]
16. Multi-target spectral moment: QSAR for antifungal drugs vs. different fungi species.
Prado-Prado FJ; Borges F; Perez-Montoto LG; González-Díaz H
Eur J Med Chem; 2009 Oct; 44(10):4051-6. PubMed ID: 19467743
[TBL] [Abstract][Full Text] [Related]
17. TOPS-MODE model of multiplexing neuroprotective effects of drugs and experimental-theoretic study of new 1,3-rasagiline derivatives potentially useful in neurodegenerative diseases.
Luan F; Cordeiro MN; Alonso N; García-Mera X; Caamaño O; Romero-Duran FJ; Yañez M; González-Díaz H
Bioorg Med Chem; 2013 Apr; 21(7):1870-9. PubMed ID: 23415089
[TBL] [Abstract][Full Text] [Related]
18. HP-Lattice QSAR for dynein proteins: experimental proteomics (2D-electrophoresis, mass spectrometry) and theoretic study of a Leishmania infantum sequence.
Dea-Ayuela MA; Pérez-Castillo Y; Meneses-Marcel A; Ubeira FM; Bolas-Fernández F; Chou KC; González-Díaz H
Bioorg Med Chem; 2008 Aug; 16(16):7770-6. PubMed ID: 18662882
[TBL] [Abstract][Full Text] [Related]
19. Quantitative Proteome-Property Relationships (QPPRs). Part 1: finding biomarkers of organic drugs with mean Markov connectivity indices of spiral networks of blood mass spectra.
Cruz-Monteagudo M; Munteanu CR; Borges F; Cordeiro MN; Uriarte E; González-Díaz H
Bioorg Med Chem; 2008 Nov; 16(22):9684-93. PubMed ID: 18951807
[TBL] [Abstract][Full Text] [Related]
20. Alignment-free prediction of a drug-target complex network based on parameters of drug connectivity and protein sequence of receptors.
Viña D; Uriarte E; Orallo F; González-Díaz H
Mol Pharm; 2009; 6(3):825-35. PubMed ID: 19281186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
